Sodium–glucose cotransporter 2 inhibition does not improve the acute pressure natriuresis response in rats with type 1 diabetes
Experimental Physiology · 2023
DOI: 10.1113/ep090849 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental Physiology, 2023. Verfasst von Natalie K Jones und 7 weiteren Autor:innen. Beteiligte Einrichtung: British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Sodium-Glucose Transporter 2 Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Kidney Research UK, Diabetes UK.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes mellitus (T1DM) leads to serious complications including premature cardiovascular and kidney disease. Hypertension contributes importantly to these adverse outcomes. The renal pressure natriuresis (PN) response, a key regulator of blood pressure (BP), is impaired in rats with T1DM as tubular sodium reabsorption fails to down‐regulate with increasing BP. We hypothesised that sodium–glucose cotransporter 2 (SGLT2) inhibitors, which reduce cardiovascular risk in kidney disease, would augment the PN response in T1DM rats. Non‐diabetic or T1DM (35–50 mg/kg streptozotocin i.p. ) adult male Sprague–Dawley rats were anaesthetised (thiopental 50 mg/kg i.p. ) and randomised to receive either dapagliflozin (1 mg/kg i.v. ) or vehicle. Baseline sodium excretion was measured and then BP was increased by sequential arterial ligations to induce the PN response. In non‐diabetic animals, the natriuretic and diuretic responses to increasing BP were not augmented by dapagliflozin. Dapagliflozin induced glycosuria, but this was not influenced by BP. In T1DM rats the PN response was impaired. Dapagliflozin again increased urinary glucose excretion but did not enhance PN. Inhibition of SGLT2 does not enhance the PN response in rats, either with or without T1DM. SGLT2 makes only a minor contribution to tubular sodium reabsorption and does not contribute to the impaired PN response in T1DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.
- Department of Neuroscience, Physiology and Pharmacology, Royal Free Campus, University College London, London, UK.
ORCID-Profile: Joanne Marks
Förderung
- British Heart Foundation
- Kidney Research UK
- Diabetes UK
Zitieren
APA
Jones, N. K., Costello, H. M., Monaghan, M. T., Stewart, K., Binnie, D., Marks, J., Bailey, M. A., & Culshaw, G. J. (2023). Sodium–glucose cotransporter 2 inhibition does not improve the acute pressure natriuresis response in rats with type 1 diabetes. Experimental Physiology. https://doi.org/10.1113/ep090849
Vancouver
Jones NK, Costello HM, Monaghan MT, Stewart K, Binnie D, Marks J, et al. Sodium–glucose cotransporter 2 inhibition does not improve the acute pressure natriuresis response in rats with type 1 diabetes. Experimental Physiology. 2023. doi:10.1113/ep090849
BibTeX
@article{Jones2023,
author = {Jones, Natalie K and Costello, Hannah M and Monaghan, Marie-Louise T and Stewart, Kevin and Binnie, David and Marks, Joanne and Bailey, Matthew A and Culshaw, Geoffrey J},
title = {Sodium–glucose cotransporter 2 inhibition does not improve the acute pressure natriuresis response in rats with type 1 diabetes},
journal = {Experimental Physiology},
year = {2023},
doi = {10.1113/ep090849}
}
EUVIMED